Literature DB >> 27233452

Limited versus total epithelial debridement ocular surface injury: Live fluorescence imaging of hemangiogenesis and lymphangiogenesis in Prox1-GFP/Flk1::Myr-mCherry mice.

Jin-Hong Chang1, Ilham Putra2, Yu-Hui Huang2, Michael Chang2, Kyuyeon Han2, Wei Zhong2, Xinbo Gao2, Shuangyong Wang2, Jennifer Dugas-Ford2, Tara Nguyen2, Young-Kwon Hong3, Dimitri T Azar4.   

Abstract

BACKGROUND: Immunohistochemical staining experiments have shown that both hemangiogenesis and lymphangiogenesis occur following severe corneal and conjunctival injury and that the neovascularization of the cornea often has severe visual consequences. To better understand how hemangiogenesis and lymphangiogenesis are induced by different degrees of ocular injury, we investigated patterns of injury-induced corneal neovascularization in live Prox1-GFP/Flk1::myr-mCherry mice, in which blood and lymphatic vessels can be imaged simultaneously in vivo.
METHODS: The eyes of Prox1-GFP/Flk1::myr-mCherry mice were injured according to four models based on epithelial debridement of the: A) central cornea (a 1.5-mm-diameter circle of tissue over the corneal apex), B) total cornea, C) bulbar conjunctiva, and D) cornea+bulbar conjunctiva. Corneal blood and lymphatic vessels were imaged on days 0, 3, 7, and 10 post-injury, and the percentages of the cornea containing blood and lymphatic vessels were calculated.
RESULTS: Neither central corneal nor bulbar conjunctival debridement resulted in significant vessel growth in the mouse cornea, whereas total corneal and corneal+bulbar conjunctival debridement did. On day 10 in the central cornea, total cornea, bulbar conjunctiva, and corneal+bulbar conjunctival epithelial debridement models, the percentage of the corneal surface that was occupied by blood vessels (hemangiogenesis) was 1.9±0.8%, 7.14±2.4%, 2.29±1%, and 15.05±2.14%, respectively, and the percentage of the corneal surface that was occupied by lymphatic vessels (lymphangiogenesis) was 2.45±1.51%, 4.85±0.95%, 2.95±1.27%, and 4.15±3.85%, respectively.
CONCLUSIONS: Substantial corneal debridement was required to induce corneal neovascularization in the mouse cornea, and the corneal epithelium may therefore be partially responsible for maintaining corneal avascularity. GENERAL SIGNIFICANCE: Our study demonstrates that GFP/Flk1::myr-mCherry mice are a useful model for studying coordinated hemangiogenic and lymphangiogenic responses. Published by Elsevier B.V.

Entities:  

Keywords:  Bulbar conjunctiva; Cornea; Corneal neovascularization (NV); Hemangiogenesis (HA); In vivo imaging; Lymphangiogenesis (LA)

Mesh:

Substances:

Year:  2016        PMID: 27233452      PMCID: PMC4961530          DOI: 10.1016/j.bbagen.2016.05.027

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  33 in total

Review 1.  Corneal neovascularization.

Authors:  J H Chang; E E Gabison; T Kato; D T Azar
Journal:  Curr Opin Ophthalmol       Date:  2001-08       Impact factor: 3.761

2.  Mouse corneal lymphangiogenesis model.

Authors:  Renhai Cao; Sharon Lim; Hong Ji; Yin Zhang; Yunlong Yang; Jennifer Honek; Eva-Maria Hedlund; Yihai Cao
Journal:  Nat Protoc       Date:  2011-05-19       Impact factor: 13.491

3.  Live imaging of newly formed lymphatic vessels in the cornea.

Authors:  Don Yuen; Xiufeng Wu; Alex C Kwan; Jeffrey Ledue; Hui Zhang; Tatiana Ecoiffier; Bronislaw Pytowski; Lu Chen
Journal:  Cell Res       Date:  2011-11-15       Impact factor: 25.617

4.  Comparison of limbal and conjunctival autograft transplantation in corneal surface reconstruction in rabbits.

Authors:  R J Tsai; T T Sun; S C Tseng
Journal:  Ophthalmology       Date:  1990-04       Impact factor: 12.079

5.  Comparison of limbal and peripheral human corneal epithelium in tissue culture.

Authors:  B Ebato; J Friend; R A Thoft
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-10       Impact factor: 4.799

6.  Molecular controls of lymphatic VEGFR3 signaling.

Authors:  Yong Deng; Xi Zhang; Michael Simons
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-12-18       Impact factor: 8.311

7.  Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

Authors:  Romulo J C Albuquerque; Takahiko Hayashi; Won Gil Cho; Mark E Kleinman; Sami Dridi; Atsunobu Takeda; Judit Z Baffi; Kiyoshi Yamada; Hiroki Kaneko; Martha G Green; Joe Chappell; Jörg Wilting; Herbert A Weich; Satoru Yamagami; Shiro Amano; Nobuhisa Mizuki; Jonathan S Alexander; Martha L Peterson; Rolf A Brekken; Masanori Hirashima; Seema Capoor; Tomohiko Usui; Balamurali K Ambati; Jayakrishna Ambati
Journal:  Nat Med       Date:  2009-08-09       Impact factor: 53.440

8.  Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis.

Authors:  Renhai Cao; Hong Ji; Ninghan Feng; Yin Zhang; Xiaojuan Yang; Patrik Andersson; Yuping Sun; Katerina Tritsaris; Anker Jon Hansen; Steen Dissing; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-11       Impact factor: 11.205

Review 9.  Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.

Authors:  Jessica F Yang; Amit Walia; Yu-hui Huang; Kyu-yeon Han; Mark I Rosenblatt; Dimitri T Azar; Jin-Hong Chang
Journal:  Surv Ophthalmol       Date:  2015-12-17       Impact factor: 6.048

10.  Novel characterization and live imaging of Schlemm's canal expressing Prox-1.

Authors:  Tan N Truong; Hannah Li; Young-Kwon Hong; Lu Chen
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more
  9 in total

Review 1.  Fluorescent reporter transgenic mice for in vivo live imaging of angiogenesis and lymphangiogenesis.

Authors:  Susan J Doh; Michael Yamakawa; Samuel M Santosa; Mario Montana; Kai Guo; Joseph R Sauer; Nicholas Curran; Kyu-Yeon Han; Charles Yu; Masatsugu Ema; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Angiogenesis       Date:  2018-07-03       Impact factor: 9.596

Review 2.  Strategies for reconstructing the limbal stem cell niche.

Authors:  Ghasem Yazdanpanah; Zeeshan Haq; Kai Kang; Sayena Jabbehdari; Mark L Rosenblatt; Ali R Djalilian
Journal:  Ocul Surf       Date:  2019-01-08       Impact factor: 5.033

Review 3.  Lymphangiogenesis and Lymphatic Barrier Dysfunction in Renal Fibrosis.

Authors:  Jing Liu; Chen Yu
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

4.  Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function.

Authors:  Medi Eslani; Ilham Putra; Xiang Shen; Judy Hamouie; Asha Tadepalli; Khandaker N Anwar; John A Kink; Samaneh Ghassemi; Gaurav Agnihotri; Sofiya Reshetylo; Alireza Mashaghi; Reza Dana; Peiman Hematti; Ali R Djalilian
Journal:  Stem Cells       Date:  2018-01-27       Impact factor: 6.277

5.  Simultaneous fluorescence imaging of distinct nerve and blood vessel patterns in dual Thy1-YFP and Flt1-DsRed transgenic mice.

Authors:  Samuel M Santosa; Kai Guo; Michael Yamakawa; Evguenia Ivakhnitskaia; Neeraj Chawla; Tara Nguyen; Kyu-Yeon Han; Masatsugu Ema; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Angiogenesis       Date:  2020-05-05       Impact factor: 9.596

6.  Emerging Approaches for Ocular Surface Regeneration.

Authors:  Ghasem Yazdanpanah; Sayena Jabbehdari; Ali R Djalilian
Journal:  Curr Ophthalmol Rep       Date:  2019-01-17

Review 7.  Angiogenesis and lymphangiogenesis in corneal transplantation-A review.

Authors:  Wei Zhong; Mario Montana; Samuel M Santosa; Irene D Isjwara; Yu-Hui Huang; Kyu-Yeon Han; Christopher O'Neil; Ashley Wang; Maria Soledad Cortina; Jose de la Cruz; Qiang Zhou; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Surv Ophthalmol       Date:  2017-12-27       Impact factor: 6.048

8.  Quantification of Angiogenesis and Lymphangiogenesis in the Dual ex vivo Aortic and Thoracic Duct Assay.

Authors:  Shuangyong Wang; Michael Yamakawa; Samuel M Santosa; Neeraj Chawla; Kai Guo; Mario Montana; Joelle A Hallak; Kyu-Yeon Han; Masatsugu Ema; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Protein Pept Lett       Date:  2020       Impact factor: 1.927

9.  Current and Emerging Therapies for Limbal Stem Cell Deficiency.

Authors:  Abdelrahman M Elhusseiny; Mohammad Soleimani; Taher K Eleiwa; Reem H ElSheikh; Charles R Frank; Morteza Naderan; Ghasem Yazdanpanah; Mark I Rosenblatt; Ali R Djalilian
Journal:  Stem Cells Transl Med       Date:  2022-03-31       Impact factor: 6.940

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.